Medigap and Cancer: The Short Answer
Yes, Medigap covers cancer treatment — but only after Medicare does its part first. That distinction matters more than most people realize, especially when you’re facing a diagnosis and suddenly staring at bills from oncologists, infusion centers, and imaging labs all at once.
Here’s how it actually works: Medicare Part A and Part B cover a wide range of oncology services — chemotherapy, radiation, surgery, hospital stays, certain oral cancer drugs, lab work, imaging. Medigap then steps in to pay the cost-sharing that Medicare leaves behind. Depending on which Medigap plan you have, that coverage can be the difference between paying tens of thousands of dollars out of pocket and paying almost nothing beyond your monthly premium.
I’ve talked to people who assumed their Medigap plan would cover any cancer treatment their doctor recommended. That’s not how it works, and that misunderstanding can cause real financial pain. So let’s get into the specifics.
What Medicare Actually Pays for Cancer Care — and What It Doesn’t
Before Medigap can do anything, Medicare has to approve and pay its share. So understanding Medicare’s coverage is step one.
Part B covers outpatient oncology services. That includes chemotherapy administered in a doctor’s office or outpatient clinic, radiation therapy, oncology office visits, PET scans, CT scans, MRIs, and lab work. Medicare pays 80% of the Medicare-approved amount after you meet the 2026 Part B deductible of $257. You’re responsible for the remaining 20%. On a $50,000 course of chemo, that’s $10,000 coming out of your pocket — before Medigap touches it.
Part A covers inpatient hospital stays, which often happen during cancer treatment for surgeries, complications, or intensive treatments. The 2026 Part A deductible is $1,676 per benefit period. If you’re hospitalized more than once in a year, you can hit that deductible more than once.
There are real gaps in what Medicare covers, though. Most oral chemotherapy drugs aren’t covered under Part B — they’d fall under Part D. Experimental treatments and clinical trials have complicated coverage rules. Some newer immunotherapy drugs approved after Medicare’s formulary was set may not be covered at all, or coverage may be limited. This isn’t a Medigap problem. It’s a Medicare problem, and Medigap can’t fix it.
How Medigap Plans Stack Up for Cancer Patients
Not all Medigap plans are equal when it comes to protecting you during expensive cancer treatment. The difference between a bare-bones plan and Plan G can be enormous.
Here’s a side-by-side look at how the most common plans handle the cost-sharing that shows up during oncology care:
| Medigap Plan | Part A Deductible | Part A Coinsurance | Part B Deductible | Part B Coinsurance (20%) | Typical Monthly Premium (Age 65) |
|---|---|---|---|---|---|
| Plan G | Covered | Covered | Not covered | Covered | $100–$200 |
| Plan N | Covered | Covered | Not covered | Covered (with copays) | $70–$150 |
| Plan F (pre-2020 enrollees only) | Covered | Covered | Covered | Covered | $150–$250+ |
| Plan K | 50% covered | 50% covered | Not covered | 50% covered | $50–$100 |
| Plan L | 75% covered | 75% covered | Not covered | 75% covered | $60–$120 |
For cancer patients specifically, Plan G is the one I’d point most people toward. You pay the 2026 Part B deductible of $257 once, and after that, you’re done. Medigap picks up that 20% coinsurance — every infusion, every scan, every oncology visit. That 20% adds up frightening fast when you’re getting weekly chemotherapy.
Plan N can work, but there’s a catch for heavy medical users: it charges copays (up to $20 for doctor visits, up to $50 for emergency room visits) and doesn’t cover Part B excess charges. If you’re seeing your oncologist twice a month, those copays pile up. Plan G eliminates that friction entirely.
The Mistake I See Most Often
People assume that because they have Medigap, they can go anywhere and see any doctor. That’s mostly true — Medigap doesn’t have networks the way Medicare Advantage does — but the real mistake is different.
I’ve seen people enroll in high-deductible Plan G thinking they’re saving money on premiums. And for someone healthy, maybe they are. But the high-deductible version of Plan G comes with a 2026 deductible of $2,870 before the plan pays anything. For a cancer patient getting ongoing treatment, you’ll hit that deductible and eventually come out ahead — but you need cash flow to cover costs while you’re burning through it. A 70-year-old going through radiation five days a week doesn’t always have time to do the math on whether the premium savings offset the front-loaded cost risk.
The other misconception: people think Medigap will cover drugs they take at home. It won’t. Oral chemotherapy pills, anti-nausea medications, immunotherapy drugs taken at home — those all go through Part D, your standalone drug plan. Medigap has never covered outpatient prescriptions. If you don’t have a Part D plan, or if your Part D plan doesn’t cover your specific cancer drugs well, you can be in serious trouble financially even with excellent Medigap coverage.
If you’ve just been diagnosed, the first call you should make is to your Part D plan to find out exactly how your prescribed drugs are covered. Don’t wait until you’re mid-treatment to discover a $4,000 monthly gap.
Cancer Treatment and the Medicare Advantage Alternative
This comes up all the time: can’t I just use Medicare Advantage for cancer care? You can. But I want to be direct with you about what I’ve seen.
Medicare Advantage plans have networks. If your preferred oncologist or cancer center isn’t in-network, you’re either paying significantly more or finding a different doctor. Cancer treatment isn’t the time to discover your specialist is out-of-network. Major cancer centers like MD Anderson, Memorial Sloan Kettering, or Mayo Clinic are sometimes excluded from Advantage networks entirely, or available only with high cost-sharing.
With original Medicare plus a Plan G Medigap policy, you can see any oncologist in the country who accepts Medicare. For someone who wants to access a specialized cancer center, travel to a major institution, or get a second opinion from a specialist in another state, that freedom is genuinely valuable. It’s not theoretical. I’ve seen people have to switch plans mid-cancer treatment because their Advantage plan’s network didn’t include the specialist they needed.
If you’re already on Medicare Advantage and you get a cancer diagnosis, you may have limited options for switching. That’s a conversation worth having with a broker who knows your state’s rules.
Bottom Line
For most people who want strong cancer coverage and the freedom to choose their doctors, Plan G is the right answer. You’ll pay the 2026 Part B deductible of $257 once a year, and after that, Medigap covers the 20% coinsurance that would otherwise devastate you during months of oncology treatment. Just make sure you also have a solid Part D plan in place, because Medigap won’t touch your prescriptions.
Frequently Asked Questions
Does Medigap cover chemotherapy?
Yes, if chemotherapy is administered in an outpatient setting (a clinic or doctor’s office), it’s covered under Medicare Part B. Medigap then covers your cost-sharing — the 20% coinsurance — after you’ve met the Part B deductible. Chemotherapy given during an inpatient hospital stay falls under Part A, and Medigap covers those cost-sharing amounts too, depending on your plan.
What about oral chemo pills — does Medigap cover those?
No. Oral cancer drugs taken at home are covered under Medicare Part D, not Part A or Part B. Since Medigap only fills gaps in Parts A and B, it won’t cover oral chemo. You need a standalone Part D drug plan for that, and you should check your specific drug’s coverage tier before assuming it’s affordable.
Can I get Medigap if I already have cancer?
It depends on your state and your timing. During your Medigap Open Enrollment Period — the six months that start when you’re 65 and enrolled in Part B — insurers cannot deny you coverage or charge you more because of pre-existing conditions, including cancer. Outside that window, most states allow medical underwriting, meaning insurers can deny you or charge higher premiums based on your health history. A handful of states (New York, Massachusetts, Connecticut, and a few others) have continuous open enrollment rules that are more protective. This is exactly why enrolling in Medigap during your initial window matters so much.
Is Medigap better than Medicare Advantage for cancer patients?
For most cancer patients, yes — especially those receiving ongoing treatment or who want access to specialized cancer centers. With Medigap, you’re not restricted to a network, and there are no prior authorization requirements to see specialists or get treatments. Medicare Advantage plans can work, but network restrictions, prior authorization delays, and out-of-pocket maximums that reset annually can create problems during intensive treatment. If you have a choice, original Medicare with Plan G is generally the more predictable option for serious illness.